about
Pharmacological treatment options for mast cell activation diseaseDouble-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care.Urticaria and autoimmunity: where are we now?Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.The potential role of omalizumab in the treatment of chronic urticaria.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Calcineurin inhibitors in chronic urticaria.
@en
type
label
Calcineurin inhibitors in chronic urticaria.
@en
prefLabel
Calcineurin inhibitors in chronic urticaria.
@en
P1476
Calcineurin inhibitors in chronic urticaria.
@en
P2093
David A Khan
Timothy D Trojan
P304
P356
10.1097/ACI.0B013E32835571F6
P577
2012-08-01T00:00:00Z